Single Arm, Open-labelPrimary end point: rate of AE as per CTCAE v4.0Secondary endpoints: Tumor response by CT and USG, PFS, OSOther endpoints: immune infiltration by CD3, CD4,CD8, PD-1 and PDL-1. The gene discussed is CD8A; the disease is neoplasm.